443 related articles for article (PubMed ID: 34105856)
1. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN
Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856
[TBL] [Abstract][Full Text] [Related]
2. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
[TBL] [Abstract][Full Text] [Related]
3. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
[TBL] [Abstract][Full Text] [Related]
4. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
[TBL] [Abstract][Full Text] [Related]
5. [Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?].
Braunisch MC; Bachmann Q; Hammitzsch A; Lorenz G; Geisler F; Schmaderer C; Heemann U; Moog P
Z Rheumatol; 2021 Jun; 80(5):408-417. PubMed ID: 33258019
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
Esatoglu SN; Tascilar K; Babaoğlu H; Bes C; Yurttas B; Akar S; Pehlivan O; Akleylek C; Tecer D; Seyahi E; Yuce-Inel T; Alpay-Kanitez N; Bodakci E; Tekgoz E; Colak S; Bolek EC; Koca SS; Kalyoncu U; Icacan OC; Ugurlu S; Oz HE; Hamuryudan V; Hatemi G;
Front Immunol; 2021; 12():651715. PubMed ID: 33936073
[TBL] [Abstract][Full Text] [Related]
7. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
[TBL] [Abstract][Full Text] [Related]
8. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the Off-site Monitoring Clinic (Virtual Monitoring Clinic) on the Practice of Outpatient Rheumatology in a Tertiary Centre during the COVID-19 Pandemic.
Chew LC; Yeo SI; Thumboo J
Ann Acad Med Singap; 2020 Nov; 49(11):905-908. PubMed ID: 33381785
[TBL] [Abstract][Full Text] [Related]
10. Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents.
Fernandez-Gutierrez B; Leon L; Madrid A; Rodriguez-Rodriguez L; Freites D; Font J; Mucientes A; Culebras E; Colome JI; Jover JA; Abasolo L
Ther Adv Musculoskelet Dis; 2021; 13():1759720X20962692. PubMed ID: 33613703
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Pediatric Rheumatology: A Comprehensive Study from a Leading Tertiary Center in Saudi Arabia.
Alqanatish J; Almojali A; Alfadhel A; Albelali A; Ahmed A; Alqahtani A; Alrasheed A; Alsewairi W; Alghnam S
J Epidemiol Glob Health; 2023 Dec; 13(4):676-684. PubMed ID: 37594620
[TBL] [Abstract][Full Text] [Related]
13. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?
Favalli EG; Monti S; Ingegnoli F; Balduzzi S; Caporali R; Montecucco C
Arthritis Rheumatol; 2020 Oct; 72(10):1600-1606. PubMed ID: 32506699
[TBL] [Abstract][Full Text] [Related]
14. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A
Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332
[TBL] [Abstract][Full Text] [Related]
16. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the outcomes of SARS-CoV-2 infection in children and young people followed at Portuguese pediatric rheumatology clinics.
Melo AT; Bernardo M; Pinheiro F; Rodrigues M; Torres R; Mourão AF; Carvalho S; Nascimento J; Sousa S; Santos MJ; Soares C; Cabral M; Marques RC; Reis PC; Ramos FO
ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):205-209. PubMed ID: 36056926
[TBL] [Abstract][Full Text] [Related]
18. How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?
Gulle S; Erez Y; Karakas A; Yuce Inel T; Kocaer SB; Demirci Yildirim T; Can G; Sari I; Birlik M; Onen F
J Infect Dev Ctries; 2023 Jul; 17(7):944-952. PubMed ID: 37515801
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
[TBL] [Abstract][Full Text] [Related]
20. The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study.
Ziadé N; Hmamouchi I; El Kibbi L; Abdulateef N; Halabi H; Abutiban F; Hamdi W; El Rakawi M; Eissa M; Masri B
Clin Rheumatol; 2020 Nov; 39(11):3205-3213. PubMed ID: 32996071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
